Provided by Tiger Trade Technology Pte. Ltd.

Rani Therapeutics Holdings

0.8482
+0.00820.98%
Volume:255.24K
Turnover:216.55K
Market Cap:118.24M
PE:-3.90
High:0.8599
Open:0.8501
Low:0.8360
Close:0.8400
52wk High:3.87
52wk Low:0.4404
Shares:139.40M
Float Shares:85.67M
Volume Ratio:0.79
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2174
EPS(LYR):-0.4500
ROE:-172.15%
ROA:-52.99%
PB:3.01
PE(LYR):-1.88

Loading ...

Feb 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 01, 2022

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jan 05, 2022

Major Issues Report

8-K - Current report
Nov 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 16, 2021

Major Issues Report

8-K - Current report
Nov 12, 2021

Major Issues Report

8-K - Current report
Sep 29, 2021

Major Issues Report

8-K - Current report
Sep 13, 2021

Major Issues Report

8-K - Current report
Sep 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 23, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Aug 09, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Aug 03, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jul 30, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 27, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 27, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 26, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 16, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jul 09, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jul 09, 2021

Correspondence

CORRESP [Cover] - Correspondence